Jiqi Shan

Statistics

Publications

Citations

248

H-Index

Active since

2020

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

Jiqi Shan is an author at First Affiliated Hospital of Zhengzhou University specializing in antitumor t cell responses, immunotherapy, and programmed cell death protein 1 (pd-1) pathway.

Publications per year

2020–2024

Publications

PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis

Jiqi Shan, Haiming Qin, Feng Li et al. · Immunity · 2024 · 117 citations

Life Sciences, Cancer Biology, Oncology +14

Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function

Ping Yü, Jiqi Shan, Yaqing Liu et al. · Cancer Immunology Immunotherapy · 2022 · 55 citations · Full text

Life Sciences, Immunology, Oncology +16

Augmenting the Effectiveness of CAR-T Cells by Enhanced Self-Delivery of PD-1-Neutralizing scFv

Ping Yü, Feng Li, Shufeng Nan et al. · Frontiers in Cell and Developmental Biology · 2020 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

Long Noncoding RNA lncNDEPD1 Regulates PD-1 Expression via miR-3619-5p in CD8+ T Cells

Shaoyan Cheng, Feng Li, Haiming Qin et al. · The Journal of Immunology · 2022 · 15 citations · Full text

Medicine, Immunology, Molecular Biology +15

LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 <sup>+</sup> T cells for improving anti-PD-1 antibody therapy

Jiqi Shan, Jing Wei, Ping Yü et al. · OncoImmunology · 2023 · 12 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 5